These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7632616)

  • 1. Specific interactions of progestins and anti-progestins with progesterone antibodies, plasma binding proteins and the human recombinant receptor.
    Mais DE; Hayes JS; Heap RB; Wang MW
    J Steroid Biochem Mol Biol; 1995 Jul; 54(1-2):63-9. PubMed ID: 7632616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of R5020 and RU486 binding to progesterone receptor from calf uterus.
    Hurd C; Moudgil VK
    Biochemistry; 1988 May; 27(10):3618-23. PubMed ID: 3408715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of 5 alpha-dihydroprogesterone and other progestins to female rat anterior pituitary nuclear extracts.
    Iswari S; Colas AE; Karavolas HJ
    Steroids; 1986; 47(2-3):189-203. PubMed ID: 3564086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of progestins on the progesterone receptor in guinea pig uterus.
    Saffran J; Loeser BK; Faber LE
    Adv Exp Med Biol; 1979; 117():223-39. PubMed ID: 474278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel antiprogestins Org 31806 and 31710: interaction with mammalian progesterone receptor and DNA binding of antisteroid receptor complexes.
    Mizutani T; Bhakta A; Kloosterboer HJ; Moudgil VK
    J Steroid Biochem Mol Biol; 1992 Aug; 42(7):695-704. PubMed ID: 1504008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RU486, a progestin antagonist, binds to progesterone receptors in a human endometrial cancer cell line and reverses the growth inhibition by progestins.
    Terakawa N; Shimizu I; Tanizawa O; Matsumoto K
    J Steroid Biochem; 1988 Aug; 31(2):161-6. PubMed ID: 2457133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ionic and ligand-specific effects on the DNA binding of progesterone receptor bound to the synthetic progestin R5020 and the antiprogestin RU486.
    Chao CC; Thomas TJ; Ebede P; Gallo MA; Thomas T
    Cancer Res; 1991 Aug; 51(15):3938-45. PubMed ID: 1855211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in the binding mechanism of RU486 and progesterone to the progesterone receptor.
    Skafar DF
    Biochemistry; 1991 Nov; 30(45):10829-32. PubMed ID: 1932004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progestin and antiprogestin effects on progesterone receptor transformation.
    Spilman CH; Gibson RE; Beuving DC; Campbell JA
    J Steroid Biochem; 1986 Jan; 24(1):383-9. PubMed ID: 2939296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type II antagonists impair the DNA binding of steroid hormone receptors without affecting dimerization.
    Bocquel MT; Ji J; Ylikomi T; Benhamou B; Vergezac A; Chambon P; Gronemeyer H
    J Steroid Biochem Mol Biol; 1993 Apr; 45(4):205-15. PubMed ID: 8499329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transformation of human progesterone receptor in the presence of the progestin (R5020) and the antiprogestin (RU486).
    Miller MM; Hurd C; Moudgil VK
    J Steroid Biochem; 1988 Nov; 31(5):777-83. PubMed ID: 3199817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agonist and antagonists induce homodimerization and mixed ligand heterodimerization of human progesterone receptors in vivo by a mammalian two-hybrid assay.
    Leonhardt SA; Altmann M; Edwards DP
    Mol Endocrinol; 1998 Dec; 12(12):1914-30. PubMed ID: 9849965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mammalian progesterone receptor shows differential sensitivity to sulfhydryl group modifying agents when bound to agonist and antagonist ligands.
    Moudgil VK; Anter MJ; Hurd C
    J Biol Chem; 1989 Feb; 264(4):2203-11. PubMed ID: 2914901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transactivation of progestin- and estrogen-responsive promoters by 19-nor progestins in African Green Monkey Kidney CV1 cells.
    Pasapera AM; Gutiérrez-Sagal R; García-Becerra R; Ulloa-Aguirre A; Savouret JF
    Endocrine; 2001 Dec; 16(3):217-25. PubMed ID: 11954666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of ligand binding, DNA binding and phosphorylation of progesterone receptor by two novel progesterone receptor antagonist ligands.
    Hurd C; Underwood B; Herman M; Iwasaki K; Kloosterboer HJ; Dinda S; Moudgil VK
    Mol Cell Biochem; 1997 Oct; 175(1-2):205-12. PubMed ID: 9350053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progestin-rhenium complexes: metal-labeled steroids with high receptor binding affinity, potential receptor-directed agents for diagnostic imaging or therapy.
    DiZio JP; Fiaschi R; Davison A; Jones AG; Katzenellenbogen JA
    Bioconjug Chem; 1991; 2(5):353-66. PubMed ID: 1790176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An amino-terminal truncated progesterone receptor isoform, PRc, enhances progestin-induced transcriptional activity.
    Wei LL; Hawkins P; Baker C; Norris B; Sheridan PL; Quinn PG
    Mol Endocrinol; 1996 Nov; 10(11):1379-87. PubMed ID: 8923464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of potential (anti)progestagenic endocrine disruptors using a recombinant human progesterone receptor binding and transactivation assay.
    Viswanath G; Halder S; Divya G; Majumder CB; Roy P
    Mol Cell Endocrinol; 2008 Nov; 295(1-2):1-9. PubMed ID: 18801410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative binding affinity study of progestins to the cytosol progestin receptor of endometrium in different mammals.
    Jewgenow K; Meyer HH
    Gen Comp Endocrinol; 1998 May; 110(2):118-24. PubMed ID: 9570932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of progesterone receptor binding in the ovine uterus.
    Bauer MA; Gorell TA
    Steroids; 1980 Nov; 36(5):581-91. PubMed ID: 7192894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.